USV chief on the metformin 'marathon' & shape of India's diabetes market

Prashant Tewari, managing director of the Indian generic firm USV is confident of the sustained dominance of oral medications in the diabetes segment in the country, even as new innovator therapies and strategic investments by foreign firms add to the competitive pressures.